HFCAS OpenIR
(本次检索基于用户作品认领结果)

浏览/检索结果: 共4条,第1-4条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:  Li, Ning;  Zhu, Jianqing;  Yin, Rutie;  Wang, Jing;  Pan, Lingya;  Kong, Beihua;  Zheng, Hong;  Liu, Jihong;  Wu, Xiaohua;  Wang, Li;  Huang, Yi;  Wang, Ke;  Zou, Dongling;  Zhao, Hongqin;  Wang, Chunyan;  Lu, Weiguo;  Lin, An;  Lou, Ge;  Li, Guiling;  Qu, Pengpeng;  Yang, Hongying;  Zhen, Xiaoa;  Hang, Wenzhao;  Hou, Jianmei;  Banerjee, Ashish;  Wu, Lingying
收藏  |  浏览/下载:40/0  |  提交时间:2022/12/23
Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yin, Rutie;  Li, Ning;  Wu, Lingying;  Wang, Jing;  Zhu, Jianqing;  Pan, Lingya;  Kong, Beihua;  Zheng, Hong;  Liu, Jihong;  Wu, Xiaohua;  Wang, Li;  Huang, Yi;  Wang, Ke;  Zou, Dongling;  Zhao, Hongqin;  Wang, Chunyan;  Lu, Weiguo;  Zhen, Xiaoa;  Hang, Wenzhao;  Hou, Jianmei
收藏  |  浏览/下载:39/0  |  提交时间:2022/12/23
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer and a time-to-progression after penultimate platinum-based chemotherapy of 6-12 or > 12 months: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Huang, Qidan;  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Danqing;  Yang, Jiaxin;  Wang, Jing;  Wu, Lingying;  Liu, Ziling;  Gao, Yunong;  Wang, Danbo;  Lou, Ge;  Yang, Hongying;  Zhou, Qi;  Kong, Beihua;  Huang, Yi;  Chen, Lipai;  Li, Guiling;  An, Ruifang;  Wang, Ke;  Zhang, Yu;  Yan, Xiaojian;  Lu, Xin;  Wang, Li;  Tan, Tao;  Dong, Juan
收藏  |  浏览/下载:61/0  |  提交时间:2021/11/01
Efficacy and safety of niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer with complete or partial response to the last platinum-based chemotherapy: a subgroup analysis of the phase III NORA trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Yang, Jiaxin;  Wu, Xiaohua;  Zhu, Jianqing;  Song, Liang;  Feng, Yanling;  Wang, Jing;  Wu, Lingying;  Liu, Ziling;  Gao, Yunong;  Wang, Danbo;  Lou, Ge;  Yang, Hongying;  Zhou, Qi;  Kong, Beihua;  Huang, Yi;  Chen, Lipai;  Li, Guiling;  An, Ruifang;  Wang, Ke;  Zhang, Yu;  Yan, Xiaojian;  Lu, Xin;  Wang, Li;  Tan, Tao;  Dong, Juan
收藏  |  浏览/下载:74/0  |  提交时间:2021/11/01